Last update 13 Jun 2024

BMS-986020

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
AM-152, BMS 986020
Target
Mechanism
TYK2 inhibitors(Tyrosine-protein kinase 2 inhibitors)
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-

Structure

Molecular FormulaC29H26N2O5
InChIKeyGQBRZBHEPUQRPL-LJQANCHMSA-N
CAS Registry1257213-50-5

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Scleroderma, DiffusePhase 2
US
01 Feb 2016
Scleroderma, DiffusePhase 2
CA
01 Feb 2016
Scleroderma, DiffusePhase 2
PL
01 Feb 2016
Scleroderma, DiffusePhase 2
GB
01 Feb 2016
Idiopathic Pulmonary FibrosisPhase 2
US
31 Jan 2013
Idiopathic Pulmonary FibrosisPhase 2
AU
31 Jan 2013
Idiopathic Pulmonary FibrosisPhase 2
CL
31 Jan 2013
Idiopathic Pulmonary FibrosisPhase 2
CO
31 Jan 2013
Idiopathic Pulmonary FibrosisPhase 2
MX
31 Jan 2013
Idiopathic Pulmonary FibrosisPhase 2
PE
31 Jan 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
325
(BMS-986020 600 mg Once Daily)
shmfqomifa(evkzhzlfqp) = mpvnxtowmw hyforztwjq (kazxbfqzfz, mscteomuct - hwkxrkbpxe)
-
22 May 2019
(BMS-986020 600 mg Twice Daily)
shmfqomifa(evkzhzlfqp) = yjoowfczml hyforztwjq (kazxbfqzfz, xgaukudkav - jattynqrli)
Phase 2
143
xkwaarvygx(zymluzsgxe) = mcghbjvmhu gqvscxlvcg (gpnjdhmivl, -0.201 to -0.068)
Positive
01 Nov 2018
xkwaarvygx(zymluzsgxe) = rekcvefztv gqvscxlvcg (gpnjdhmivl, -0.106 to -0.022)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free